FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022632416> ?p ?o ?g. }

• W2022632416 endingPage "422" @default.
• W2022632416 startingPage "411" @default.
• W2022632416 abstract "Pituitary adenomas are fully characterized only by immunohistochemistry. The technical limitations, gaps and peculiarities influence the pathology diagnosis. More and more data shows that clinically nonfunctioning pituitary adenomas could synthesize or secrete hormones or their subunits. The tumor pathology is monomorphous or polymorphous, difficult to differentiate from normal adjacent tissue. Light microscopy (LM) qualitative analysis using basic or special stains can differentiate between tumor and normal tissue and allows elimination of artifacts. Electron microscopy (EM) completes the diagnosis in selected cases. Pituitary adenomas immunohistochemistry was done by LM in 120 cases (84 – clinically nonfunctioning adenomas – NFA and 36 acromegalics with or without PRL secreting adenomas - ACM) using the avidine-biotin complex method. In 26 cases we determined by EM the immunoreactive cells (17 NFA and 9 ACM) using the immunogold method. We observed high tumor immunoreactivity (mono or plurihormonal) in 43/84 (51%) NFA, 13/36 (36%) ACM respectively. Serum excess hormones and tissue immunoreactivity were significantly concordant for prolactin in NFA cases and for GH, in ACM cases (p<0.05). Mute pituitary adenomas have no clinical expression of hormonal products either they produce biologically inactive components or they synthesize but do not secrete hormones in sufficient amounts to increase serum level and to determine a systemic response. A concordance between LM and EM immunoreactivity was observed only for GH in ACM patients group (p<0.05). The differences could be due to dimensions of the samples or the number of granules inside of the cells (sparsely granulated adenomas are negative or low immunoreactive at the LM level). EM evaluation of NFA identified 2 oncocytomas and 4 null cell adenomas. The complete evaluation of pituitary adenomas includ a qualitative and quantitative analysis at the LM level using special methods, validated at the EM level in order to identify clinically mute immunoreactive cells – a possible target for specific drugs therapies in the future." @default.
• W2022632416 created "2016-06-24" @default.
• W2022632416 creator A5013145818 @default.
• W2022632416 date "2005-01-01" @default.
• W2022632416 modified "2023-09-25" @default.
• W2022632416 title "Mind the gap in immunohistochemical techniques used in pathology of pituitary adenomas" @default.
• W2022632416 cites W1506710116 @default.
• W2022632416 cites W1508086709 @default.
• W2022632416 cites W1519399351 @default.
• W2022632416 cites W1584002126 @default.
• W2022632416 cites W1863962395 @default.
• W2022632416 cites W1977800889 @default.
• W2022632416 cites W1980137501 @default.
• W2022632416 cites W1985068146 @default.
• W2022632416 cites W1988680000 @default.
• W2022632416 cites W2003589817 @default.
• W2022632416 cites W2008140214 @default.
• W2022632416 cites W2029733982 @default.
• W2022632416 cites W2056267591 @default.
• W2022632416 cites W2060907798 @default.
• W2022632416 cites W2064963775 @default.
• W2022632416 cites W2091402431 @default.
• W2022632416 cites W2096428903 @default.
• W2022632416 cites W2113252301 @default.
• W2022632416 cites W2405877639 @default.
• W2022632416 cites W2413055468 @default.
• W2022632416 cites W2886258311 @default.
• W2022632416 doi "https://doi.org/10.4183/aeb.2005.411" @default.
• W2022632416 hasPublicationYear "2005" @default.
• W2022632416 type Work @default.
• W2022632416 sameAs 2022632416 @default.
• W2022632416 citedByCount "3" @default.
• W2022632416 countsByYear W20226324162016 @default.
• W2022632416 countsByYear W20226324162017 @default.
• W2022632416 countsByYear W20226324162021 @default.
• W2022632416 crossrefType "journal-article" @default.
• W2022632416 hasAuthorship W2022632416A5013145818 @default.
• W2022632416 hasConcept C142724271 @default.
• W2022632416 hasConcept C204232928 @default.
• W2022632416 hasConcept C2777428134 @default.
• W2022632416 hasConcept C2779318953 @default.
• W2022632416 hasConcept C71924100 @default.
• W2022632416 hasConceptScore W2022632416C142724271 @default.
• W2022632416 hasConceptScore W2022632416C204232928 @default.
• W2022632416 hasConceptScore W2022632416C2777428134 @default.
• W2022632416 hasConceptScore W2022632416C2779318953 @default.
• W2022632416 hasConceptScore W2022632416C71924100 @default.
• W2022632416 hasIssue "4" @default.
• W2022632416 hasLocation W20226324161 @default.
• W2022632416 hasOpenAccess W2022632416 @default.
• W2022632416 hasPrimaryLocation W20226324161 @default.
• W2022632416 hasRelatedWork W1034161964 @default.
• W2022632416 hasRelatedWork W1980633279 @default.
• W2022632416 hasRelatedWork W201409066 @default.
• W2022632416 hasRelatedWork W2088496903 @default.
• W2022632416 hasRelatedWork W2348680903 @default.
• W2022632416 hasRelatedWork W2350134505 @default.
• W2022632416 hasRelatedWork W2366082711 @default.
• W2022632416 hasRelatedWork W2379776538 @default.
• W2022632416 hasRelatedWork W2384887821 @default.
• W2022632416 hasRelatedWork W3031036733 @default.
• W2022632416 hasVolume "1" @default.
• W2022632416 isParatext "false" @default.
• W2022632416 isRetracted "false" @default.
• W2022632416 magId "2022632416" @default.
• W2022632416 workType "article" @default.